Business ❯Pharmaceutical Industry ❯Market Competition

Drug Pricing

Novo Nordisk Cost Analysis Insurance Coverage Consumer Health Weight Loss Solutions Compounded Drugs Merck Access to Medication

9 ARTICLES

2w ago

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

The pharmaceutical company has filed lawsuits against four telehealth providers, intensifying its campaign to halt unapproved versions of its diabetes and weight-loss medications.

6 ARTICLES

last mo.

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

8 ARTICLES

2mo ago

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients

3 ARTICLES

2mo ago

Amgen Advances Weight-Loss Drug MariTide with Two Phase 3 Trials

7 ARTICLES

2mo ago

Eli Lilly Expands Zepbound Access with New Doses and Lower Prices

3 ARTICLES

8mo ago

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial